Pavel Tishuk
Neurology · Newton, NJNPI 1205088572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $994 and has fallen 87.6% since, to $124 in 2023.
Across 178 payments — averaging $13.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$545
- UCB, Inc.$276
- AbbVie$217
- Biohaven Pharmaceuticals, Inc.$172
- SK Life Science, Inc.$163
- Biogen$151
- plus $832 from 20 others
What the payments were for
- Food & beverage$2,347100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 37 | $545 |
| UCB, Inc. | 23 | $276 |
| AbbVie(2 entities) | 8 | $217 |
| Biohaven Pharmaceuticals, Inc. | 24 | $172 |
| SK Life Science, Inc. | 9 | $163 |
| Biogen | 15 | $151 |
| Supernus Pharmaceuticals, Inc. | 11 | $133 |
| Avanir Pharmaceuticals, Inc. | 8 | $101 |
| AstraZeneca | 8 | $100 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| E.r. Squibb & Sons, L.L.C. | 4 | $63 |
| Kyowa Kirin, Inc. | 3 | $46 |
| Lilly USA, LLC | 3 | $41 |
| Amgen | 3 | $40 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Bristol Myers Squibb | 2 | $28 |
| Grifols USA, LLC | 2 | $27 |
| Neurocrine Biosciences, Inc. | 2 | $23 |
| EMD Serono, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| CSL Behring | 1 | $15 |
| Sanofi | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| Lundbeck LLC | 1 | $12 |
| Adamas Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,356 in reported general payments places this provider in the 55th percentile of 521 neurology providers in New Jersey.
Other neurology in Newton
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
- Ashish KapoorBayonne$329K
- Mario VukicHackensack$310K
- Andrew SylvesterBridgewater$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.